Literature DB >> 22393167

Preservation of neurons of the nucleus basalis in subcortical ischemic vascular disease.

San Jung1, Chris Zarow, Wendy J Mack, Ling Zheng, Harry V Vinters, William G Ellis, Scott A Lyness, Helena C Chui.   

Abstract

OBJECTIVE: To investigate loss of neurons in the nucleus basalis (NB) of Meynert in patients with subcortical ischemic vascular disease (SIVD) compared with healthy controls, patients with Alzheimer disease (AD), and patients with mixed AD and SIVD.
DESIGN: Autopsied cases drawn from a longitudinal observational study of patients with SIVD, patients with AD, and healthy controls.
SETTING: Multi center, university-affiliated, program project neuropathology core. PATIENTS: Patients with pathologically defined SIVD (n = 16), AD (n = 20), and mixed AD and SIVD (n = 10) and healthy controls matched by age and educational level (n = 17) were studied. MAIN OUTCOME MEASURES: The NB neuronal cell counts in each group and their correlation with the extent of magnetic resonance imaging white matter lesions and Clinical Dementia Rating (CDR) scores closest to death.
RESULTS: No significant loss of neurons was found in SIVD patients compared with age-matched controls in contrast to the AD and mixed groups, who had significant neuronal loss. A significant inverse correlation between NB neurons and CDR scores was found in the AD group but not in the SIVD and mixed groups. The NB cell counts were not correlated with either the extent of white matter lesions or cortical gray matter volume in the SIVD or AD groups.
CONCLUSIONS: These findings inveigh against primary loss of cholinergic neurons in SIVD patients but do not rule out the possibility of secondary cholinergic deficits due to disruptions of cholinergic projections to cerebral cortex.

Entities:  

Mesh:

Year:  2012        PMID: 22393167      PMCID: PMC4184885          DOI: 10.1001/archneurol.2011.2874

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  40 in total

1.  Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease.

Authors:  I Iraizoz; S de Lacalle; L M Gonzalo
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

Review 2.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

Authors:  I G McKeith; D Galasko; K Kosaka; E K Perry; D W Dickson; L A Hansen; D P Salmon; J Lowe; S S Mirra; E J Byrne; G Lennox; N P Quinn; J A Edwardson; P G Ince; C Bergeron; A Burns; B L Miller; S Lovestone; D Collerton; E N Jansen; C Ballard; R A de Vos; G K Wilcock; K A Jellinger; R H Perry
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

Review 3.  Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease.

Authors:  O J Vogels; C A Broere; H J ter Laak; H J ten Donkelaar; R Nieuwenhuys; B P Schulte
Journal:  Neurobiol Aging       Date:  1990 Jan-Feb       Impact factor: 4.673

Review 4.  MRI segmentation: methods and applications.

Authors:  L P Clarke; R P Velthuizen; M A Camacho; J J Heine; M Vaidyanathan; L O Hall; R W Thatcher; M L Silbiger
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546

5.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

6.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers.

Authors:  H C Chui; J I Victoroff; D Margolin; W Jagust; R Shankle; R Katzman
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

Review 7.  Staging of Alzheimer-related cortical destruction.

Authors:  H Braak; E Braak; J Bohl
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

8.  Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.

Authors:  S Lehéricy; E C Hirsch; P Cervera-Piérot; L B Hersh; S Bakchine; F Piette; C Duyckaerts; J J Hauw; F Javoy-Agid; Y Agid
Journal:  J Comp Neurol       Date:  1993-04-01       Impact factor: 3.215

9.  Topography of brain atrophy during normal aging and Alzheimer's disease.

Authors:  K L Double; G M Halliday; J J Kril; J A Harasty; K Cullen; W S Brooks; H Creasey; G A Broe
Journal:  Neurobiol Aging       Date:  1996 Jul-Aug       Impact factor: 4.673

10.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

View more
  8 in total

1.  Cerebral atherosclerosis is associated with cystic infarcts and microinfarcts but not Alzheimer pathologic changes.

Authors:  Ling Zheng; Harry V Vinters; Wendy J Mack; Chris Zarow; William G Ellis; Helena C Chui
Journal:  Stroke       Date:  2013-07-25       Impact factor: 7.914

2.  Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition.

Authors:  Ling Zheng; Harry V Vinters; Wendy J Mack; Michael W Weiner; Helena C Chui
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 3.  Update on the Neurobiology of Vascular Cognitive Impairment: From Lab to Clinic.

Authors:  Luisa Vinciguerra; Giuseppe Lanza; Valentina Puglisi; Francesco Fisicaro; Manuela Pennisi; Rita Bella; Mariagiovanna Cantone
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

Review 4.  Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit.

Authors:  Paola Caruso; Riccardo Signori; Rita Moretti
Journal:  Vasc Health Risk Manag       Date:  2019-08-07

Review 5.  Homocysteine in Neurology: A Possible Contributing Factor to Small Vessel Disease.

Authors:  Rita Moretti; Mauro Giuffré; Paola Caruso; Silvia Gazzin; Claudio Tiribelli
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

6.  Pathology and pathogenesis of vascular cognitive impairment-a critical update.

Authors:  Kurt A Jellinger
Journal:  Front Aging Neurosci       Date:  2013-04-10       Impact factor: 5.750

7.  White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia.

Authors:  Qing Liu; Zude Zhu; Stefan J Teipel; Jianwei Yang; Yi Xing; Yi Tang; Jianping Jia
Journal:  Front Aging Neurosci       Date:  2017-02-27       Impact factor: 5.750

Review 8.  Small Vessel Disease-Related Dementia: An Invalid Neurovascular Coupling?

Authors:  Rita Moretti; Paola Caruso
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.